Therefore, pre-surgical treatment with Vitamin D3 (1,25-D3) increased intratumoral T cell infiltration (possibly through decreased CD34+ count) and early activation marker expressing cells with a concomitant reduction in HNSCC recurrence rate. The gene discussed is CD34; the disease is head and neck squamous cell carcinoma.